Holen Sie sich die Stockscreener-App
0.50
2.20%
-0.0113
Finanzdaten der Xilio Therapeutics Inc-Aktie (XLO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
135.85%
19.07
|
8.084 | 2.93 | 1.724 | 2.263 |
Operating Expenses
|
6.48%
21.00
|
22.45 | 16.78 | 15.35 | 17.02 |
| Benefits Costs and Expenses |
-
|
- | 16.20 | 14.82 | - |
| Costs And Expenses |
6.48%
21.00
|
22.45 | 16.20 | 14.82 | 17.02 |
| Operating Income/Loss |
86.57%
-1.929
|
-14.37 | -13.85 | -13.63 | -14.76 |
| Nonoperating Income/Loss |
871.45%
-14.36
|
-1.478 | 0.586 | 0.536 | 0.742 |
| Income/Loss From Continuing Operations Before Tax |
135.85%
19.07
|
8.084 | -13.27 | -13.09 | 2.263 |
| Income/Loss From Continuing Operations After Tax |
2.80%
-16.29
|
-15.84 | -13.27 | -13.09 | -14.02 |
|
Net Income/Loss
|
2.80%
-16.29
|
-15.84 | -13.27 | -13.09 | -14.02 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
49.41%
144.11
|
96.45 | 74.70 | 3.7486 | 63.47 |
| Basic Earnings Per Share |
31.25%
-0.11
|
-0.16 | -0.18 | -0.18 | -0.22 |
| Diluted Earnings Per Share |
31.25%
-0.11
|
-0.16 | -0.18 | -0.18 | -0.22 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.18%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):